ClinicalTrials.Veeva

Menu
A

Arizona Clinical Trials | Chandler, AZ

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

MK-1084
CRB-913
MK-8527-015
Maridebart Cafraglutide
MK-8527
BI 1584862

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 5 total trials
Locations recently updated

A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity (CANYON-1)

This study will assess the safety of the investigational drug CRB-913 and how it is processed in the body.The study has two parts: Part 1 will measur...

Enrolling
Obese But Otherwise Healthy Participants
Drug: CRB-913
Drug: Placebo

The purpose of this study is to learn what happens to calderasib levels in a person's body over time. Researchers will measure what happens to calder...

Enrolling
Hepatic Impairment
Healthy
Drug: Calderasib

This study is open to adults between 18 and 80 years of age. People with a body mass index (BMI) between 18 and 42 kg/m2 can take part. This study in...

Enrolling
Hepatic Insufficiency
Drug: BI 1584862
Status recently updated

The main objective of this trial will be to determine whether maridebart cafraglutide is superior to placebo on reduction in liver fat content and bo...

Not yet enrolling
Enrolling
Overweight or Obesity and Elevated Liver Fat
Drug: Placebo
Drug: Maridebart cafraglutide

Trial sponsors

Merck Sharp & Dohme (MSD) logo
Amgen logo
Boehringer Ingelheim logo
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems